25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Genelux Corporation Common Stock
Buy, Hold or Sell?

Let's analyze Genelux together

I guess you are interested in Genelux Corporation Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genelux Corporation Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Genelux Corporation Common Stock

I send you an email if I find something interesting about Genelux Corporation Common Stock.

1. Quick Overview

1.1. Quick analysis of Genelux (30 sec.)










1.2. What can you expect buying and holding a share of Genelux? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.09
Expected worth in 1 year
$1.54
How sure are you?
27.8%

+ What do you gain per year?

Total Gains per Share
$0.45
Return On Investment
15.4%

For what price can you sell your share?

Current Price per Share
$2.90
Expected price per share
$1.95 - $3.5
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Genelux (5 min.)




Live pricePrice per Share (EOD)
$2.90
Intrinsic Value Per Share
$-9.00 - $-10.69
Total Value Per Share
$-7.91 - $-9.60

2.2. Growth of Genelux (5 min.)




Is Genelux growing?

Current yearPrevious yearGrowGrow %
How rich?$37.6m-$10.7m$34.8m144.8%

How much money is Genelux making?

Current yearPrevious yearGrowGrow %
Making money-$6.6m-$4.6m-$1.9m-30.0%
Net Profit Margin-24,646.8%-3,303.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Genelux (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Genelux?

Welcome investor! Genelux's management wants to use your money to grow the business. In return you get a share of Genelux.

First you should know what it really means to hold a share of Genelux. And how you can make/lose money.

Speculation

The Price per Share of Genelux is $2.9. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genelux.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genelux, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.09. Based on the TTM, the Book Value Change Per Share is $0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $0.44 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genelux.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.19-6.6%-0.19-6.6%-0.11-3.6%-0.13-4.3%-0.13-4.3%
Usd Book Value Change Per Share0.6522.6%0.113.8%0.4415.3%0.062.1%0.062.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.6522.6%0.113.8%0.4415.3%0.062.1%0.062.1%
Usd Price Per Share1.95-11.72-15.12-5.96-5.96-
Price to Earnings Ratio-2.56--16.77--17.91--7.71--7.71-
Price-to-Total Gains Ratio2.98-80.87-41.33-67.69-67.69-
Price to Book Ratio1.79-19.14-101.69-26.85-26.85-
Price-to-Total Gains Ratio2.98-80.87-41.33-67.69-67.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.9
Number of shares344
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.110.06
Usd Total Gains Per Share0.110.06
Gains per Quarter (344 shares)38.3820.85
Gains per Year (344 shares)153.5383.38
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1015414408373
203072980167156
304614520250239
406146060334322
507687600417405
609219140500488
70107510680584571
80122812220667654
90138213760750737
100153515300834820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share2.02.00.050.0%5.06.01.041.7%5.08.05.027.8%5.08.05.027.8%5.08.05.027.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share2.02.00.050.0%5.06.01.041.7%5.08.05.027.8%5.08.05.027.8%5.08.05.027.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Genelux Corporation Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6540.112+486%0.444+47%0.061+979%0.061+979%
Book Value Per Share--1.0910.697+57%-0.312+129%-0.166+115%-0.166+115%
Current Ratio--6.0093.995+50%1.244+383%1.424+322%1.424+322%
Debt To Asset Ratio--0.1660.288-42%3.700-96%3.143-95%3.143-95%
Debt To Equity Ratio--0.1990.421-53%1.210-84%0.363-45%0.363-45%
Dividend Per Share----0%-0%-0%-0%
Eps---0.190-0.192+1%-0.105-45%-0.126-34%-0.126-34%
Free Cash Flow Per Share---0.204-0.161-21%-0.105-48%-0.081-60%-0.081-60%
Free Cash Flow To Equity Per Share--0.5990.094+538%0.166+261%0.044+1248%0.044+1248%
Gross Profit Margin--0.9690.977-1%1.000-3%0.995-3%0.995-3%
Intrinsic Value_10Y_max---10.687--------
Intrinsic Value_10Y_min---9.002--------
Intrinsic Value_1Y_max---0.467--------
Intrinsic Value_1Y_min---0.458--------
Intrinsic Value_3Y_max---1.863--------
Intrinsic Value_3Y_min---1.769--------
Intrinsic Value_5Y_max---3.814--------
Intrinsic Value_5Y_min---3.501--------
Market Cap100152950.000+33%67344225.000404756060.000-83%522004082.500-87%205946698.333-67%205946698.333-67%
Net Profit Margin----246.4680%-33.0300%-62.1110%-62.1110%
Operating Margin----254.7890%-20.7340%-61.2270%-61.2270%
Operating Ratio---255.039-100%22.760-100%61.733-100%61.733-100%
Pb Ratio2.659+33%1.78819.139-91%101.695-98%26.852-93%26.852-93%
Pe Ratio-3.808-49%-2.560-16.767+555%-17.910+600%-7.706+201%-7.706+201%
Price Per Share2.900+33%1.95011.720-83%15.115-87%5.963-67%5.963-67%
Price To Free Cash Flow Ratio-3.551-49%-2.387-22.536+844%-24.890+943%-10.539+341%-10.539+341%
Price To Total Gains Ratio4.434+33%2.98280.866-96%41.328-93%67.687-96%67.687-96%
Quick Ratio--10.2385.950+72%1.126+810%1.812+465%1.812+465%
Return On Assets---0.146-0.216+48%-0.242+66%-0.729+401%-0.729+401%
Return On Equity---0.175-0.316+81%-1.404+704%-0.382+119%-0.382+119%
Total Gains Per Share--0.6540.112+486%0.444+47%0.061+979%0.061+979%
Usd Book Value--37669000.00024063500.000+57%-10791750.000+129%-5728625.000+115%-5728625.000+115%
Usd Book Value Change Per Share--0.6540.112+486%0.444+47%0.061+979%0.061+979%
Usd Book Value Per Share--1.0910.697+57%-0.312+129%-0.166+115%-0.166+115%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.190-0.192+1%-0.105-45%-0.126-34%-0.126-34%
Usd Free Cash Flow---7052000.000-5555750.000-21%-3633500.000-48%-2787000.000-60%-2787000.000-60%
Usd Free Cash Flow Per Share---0.204-0.161-21%-0.105-48%-0.081-60%-0.081-60%
Usd Free Cash Flow To Equity Per Share--0.5990.094+538%0.166+261%0.044+1248%0.044+1248%
Usd Market Cap100152950.000+33%67344225.000404756060.000-83%522004082.500-87%205946698.333-67%205946698.333-67%
Usd Price Per Share2.900+33%1.95011.720-83%15.115-87%5.963-67%5.963-67%
Usd Profit---6576000.000-6634500.000+1%-4643000.000-29%-4561666.667-31%-4561666.667-31%
Usd Revenue---368000.000-100%2809500.000-100%706111.111-100%706111.111-100%
Usd Total Gains Per Share--0.6540.112+486%0.444+47%0.061+979%0.061+979%
 EOD+6 -2MRQTTM+21 -11YOY+18 -145Y+18 -1410Y+18 -14

3.3 Fundamental Score

Let's check the fundamental score of Genelux Corporation Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.808
Price to Book Ratio (EOD)Between0-12.659
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.238
Current Ratio (MRQ)Greater than16.009
Debt to Asset Ratio (MRQ)Less than10.166
Debt to Equity Ratio (MRQ)Less than10.199
Return on Equity (MRQ)Greater than0.15-0.175
Return on Assets (MRQ)Greater than0.05-0.146
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Genelux Corporation Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.051
Ma 20Greater thanMa 502.903
Ma 50Greater thanMa 1002.613
Ma 100Greater thanMa 2002.365
OpenGreater thanClose2.920
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Genelux Corporation Common Stock

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT Immunotherapy for treating pancreatic cancer. Genelux Corporation has a licensing agreement with ELIAS Animal Health, LLC for V-VET1, a clinical stage animal health product candidate. The company was incorporated in 2001 and is headquartered in Westlake Village, California.

Fundamental data was last updated by Penke on 2024-10-30 19:01:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Genelux earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genelux to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genelux Corporation Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-24,646.8%+24,646.8%
TTM-24,646.8%YOY-3,303.0%-21,343.8%
TTM-24,646.8%5Y-6,211.1%-18,435.7%
5Y-6,211.1%10Y-6,211.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--135.3%+135.3%
TTM-24,646.8%-204.4%-24,442.4%
YOY-3,303.0%-207.5%-3,095.5%
5Y-6,211.1%-353.2%-5,857.9%
10Y-6,211.1%-464.5%-5,746.6%
4.3.1.2. Return on Assets

Shows how efficient Genelux is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genelux to the Biotechnology industry mean.
  • -14.6% Return on Assets means that Genelux generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genelux Corporation Common Stock:

  • The MRQ is -14.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.6%TTM-21.6%+7.0%
TTM-21.6%YOY-24.2%+2.6%
TTM-21.6%5Y-72.9%+51.3%
5Y-72.9%10Y-72.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.6%-10.7%-3.9%
TTM-21.6%-11.8%-9.8%
YOY-24.2%-11.0%-13.2%
5Y-72.9%-12.6%-60.3%
10Y-72.9%-14.3%-58.6%
4.3.1.3. Return on Equity

Shows how efficient Genelux is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genelux to the Biotechnology industry mean.
  • -17.5% Return on Equity means Genelux generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genelux Corporation Common Stock:

  • The MRQ is -17.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -31.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.5%TTM-31.6%+14.2%
TTM-31.6%YOY-140.4%+108.8%
TTM-31.6%5Y-38.2%+6.6%
5Y-38.2%10Y-38.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.5%-13.5%-4.0%
TTM-31.6%-15.9%-15.7%
YOY-140.4%-13.5%-126.9%
5Y-38.2%-18.5%-19.7%
10Y-38.2%-19.0%-19.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Genelux Corporation Common Stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Genelux is operating .

  • Measures how much profit Genelux makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genelux to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genelux Corporation Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-25,478.9%+25,478.9%
TTM-25,478.9%YOY-2,073.4%-23,405.6%
TTM-25,478.9%5Y-6,122.7%-19,356.2%
5Y-6,122.7%10Y-6,122.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--277.1%+277.1%
TTM-25,478.9%-312.4%-25,166.5%
YOY-2,073.4%-223.5%-1,849.9%
5Y-6,122.7%-384.9%-5,737.8%
10Y-6,122.7%-494.6%-5,628.1%
4.3.2.2. Operating Ratio

Measures how efficient Genelux is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM255.039-255.039
TTM255.039YOY22.760+232.279
TTM255.0395Y61.733+193.306
5Y61.73310Y61.7330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.842-2.842
TTM255.0393.179+251.860
YOY22.7603.301+19.459
5Y61.7334.794+56.939
10Y61.7336.520+55.213
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Genelux Corporation Common Stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Genelux is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.01 means the company has $6.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 6.009. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.995. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.009TTM3.995+2.014
TTM3.995YOY1.244+2.751
TTM3.9955Y1.424+2.571
5Y1.42410Y1.4240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0093.783+2.226
TTM3.9953.923+0.072
YOY1.2444.715-3.471
5Y1.4245.960-4.536
10Y1.4246.285-4.861
4.4.3.2. Quick Ratio

Measures if Genelux is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genelux to the Biotechnology industry mean.
  • A Quick Ratio of 10.24 means the company can pay off $10.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 10.238. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.950. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.238TTM5.950+4.289
TTM5.950YOY1.126+4.824
TTM5.9505Y1.812+4.138
5Y1.81210Y1.8120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2383.349+6.889
TTM5.9503.522+2.428
YOY1.1264.691-3.565
5Y1.8125.927-4.115
10Y1.8126.469-4.657
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Genelux Corporation Common Stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Genelux assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genelux to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.17 means that Genelux assets are financed with 16.6% credit (debt) and the remaining percentage (100% - 16.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 0.166. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.288. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.166TTM0.288-0.122
TTM0.288YOY3.700-3.412
TTM0.2885Y3.143-2.855
5Y3.14310Y3.1430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1660.338-0.172
TTM0.2880.347-0.059
YOY3.7000.309+3.391
5Y3.1430.365+2.778
10Y3.1430.380+2.763
4.5.4.2. Debt to Equity Ratio

Measures if Genelux is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genelux to the Biotechnology industry mean.
  • A Debt to Equity ratio of 19.9% means that company has $0.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 0.199. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.421. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.199TTM0.421-0.222
TTM0.421YOY1.210-0.789
TTM0.4215Y0.363+0.059
5Y0.36310Y0.3630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1990.389-0.190
TTM0.4210.437-0.016
YOY1.2100.375+0.835
5Y0.3630.450-0.087
10Y0.3630.488-0.125
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genelux generates.

  • Above 15 is considered overpriced but always compare Genelux to the Biotechnology industry mean.
  • A PE ratio of -2.56 means the investor is paying $-2.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genelux Corporation Common Stock:

  • The EOD is -3.808. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.560. Based on the earnings, the company is expensive. -2
  • The TTM is -16.767. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.808MRQ-2.560-1.247
MRQ-2.560TTM-16.767+14.206
TTM-16.767YOY-17.910+1.143
TTM-16.7675Y-7.706-9.061
5Y-7.70610Y-7.7060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.808-2.431-1.377
MRQ-2.560-2.454-0.106
TTM-16.767-2.994-13.773
YOY-17.910-3.435-14.475
5Y-7.706-6.005-1.701
10Y-7.706-6.275-1.431
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genelux Corporation Common Stock:

  • The EOD is -3.551. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.387. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -22.536. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.551MRQ-2.387-1.163
MRQ-2.387TTM-22.536+20.149
TTM-22.536YOY-24.890+2.353
TTM-22.5365Y-10.539-11.997
5Y-10.53910Y-10.5390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.551-3.231-0.320
MRQ-2.387-3.234+0.847
TTM-22.536-3.528-19.008
YOY-24.890-4.567-20.323
5Y-10.539-8.099-2.440
10Y-10.539-8.945-1.594
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Genelux is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.79 means the investor is paying $1.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genelux Corporation Common Stock:

  • The EOD is 2.659. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.788. Based on the equity, the company is underpriced. +1
  • The TTM is 19.139. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.659MRQ1.788+0.871
MRQ1.788TTM19.139-17.351
TTM19.139YOY101.695-82.556
TTM19.1395Y26.852-7.713
5Y26.85210Y26.8520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6591.938+0.721
MRQ1.7881.983-0.195
TTM19.1392.193+16.946
YOY101.6952.392+99.303
5Y26.8523.608+23.244
10Y26.8524.220+22.632
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Genelux Corporation Common Stock.

4.8.3. Insider Transactions

Insiders are holding 16.285% of the shares of Genelux Corporation Common Stock.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-09-13Aladar SzalaySELL330802.57
2024-09-11Aladar SzalaySELL313762.62
2024-09-11James L TyreeSELL17302.6
2024-09-09Aladar SzalaySELL233832.7
2024-09-03Aladar SzalaySELL428182.09
2024-08-29Aladar SzalaySELL1070451.98
2024-08-27Aladar SzalaySELL516302.11
2024-08-23Aladar SzalaySELL400002.29
2024-06-24Yong YuSELL68492.12
2024-06-24Sean RyderSELL54962.12
2024-06-24Caroline JewettSELL49612.12
2024-05-15Aladar SzalaySELL170943.66
2024-05-13Aladar SzalaySELL34463.62
2024-05-07Aladar SzalaySELL60253.67
2024-05-01Aladar SzalaySELL330613.3
2024-04-29Aladar SzalaySELL64033.25
2024-04-24Aladar SzalaySELL80643.5
2024-04-22Aladar SzalaySELL143313.53
2024-04-16Aladar SzalaySELL486833.53
2023-12-13John ThomasSELL900013.38
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets45,179
Total Liabilities7,510
Total Stockholder Equity37,669
 As reported
Total Liabilities 7,510
Total Stockholder Equity+ 37,669
Total Assets = 45,179

Assets

Total Assets45,179
Total Current Assets34,870
Long-term Assets10,309
Total Current Assets
Cash And Cash Equivalents 7,858
Short-term Investments 25,778
Other Current Assets 1,234
Total Current Assets  (as reported)34,870
Total Current Assets  (calculated)34,870
+/-0
Long-term Assets
Property Plant Equipment 3,404
Long Term Investments 6,813
Long-term Assets Other 92
Long-term Assets  (as reported)10,309
Long-term Assets  (calculated)10,309
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,803
Long-term Liabilities1,707
Total Stockholder Equity37,669
Total Current Liabilities
Short-term Debt 500
Accounts payable 4,786
Other Current Liabilities 517
Total Current Liabilities  (as reported)5,803
Total Current Liabilities  (calculated)5,803
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,707
Long-term Liabilities  (as reported)1,707
Long-term Liabilities  (calculated)1,707
+/- 0
Total Stockholder Equity
Common Stock35
Retained Earnings -235,950
Accumulated Other Comprehensive Income -11
Other Stockholders Equity 273,595
Total Stockholder Equity (as reported)37,669
Total Stockholder Equity (calculated)37,669
+/-0
Other
Capital Stock35
Cash and Short Term Investments 33,636
Common Stock Shares Outstanding 29,689
Liabilities and Stockholders Equity 45,179
Net Debt -5,651
Net Invested Capital 37,669
Net Working Capital 29,067
Property Plant and Equipment Gross 6,975
Short Long Term Debt Total 2,207



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
3,502
3,502
3,502
3,502
2,032
2,032
2,032
8,126
10,204
9,131
6,189
5,531
14,616
31,363
34,072
27,893
24,676
45,179
45,17924,67627,89334,07231,36314,6165,5316,1899,13110,2048,1262,0322,0322,0323,5023,5023,5023,502
   > Total Current Assets 
2,869
2,869
2,869
2,869
1,456
1,456
1,456
5,822
8,125
6,043
2,861
1,892
12,056
28,683
31,179
24,203
21,204
34,870
34,87021,20424,20331,17928,68312,0561,8922,8616,0438,1255,8221,4561,4561,4562,8692,8692,8692,869
       Cash And Cash Equivalents 
2,838
2,838
2,838
2,838
1,124
1,124
1,124
4,495
7,175
4,202
1,370
397
10,338
27,140
29,869
9,418
4,061
7,858
7,8584,0619,41829,86927,14010,3383971,3704,2027,1754,4951,1241,1241,1242,8382,8382,8382,838
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,773
15,566
25,778
25,77815,56613,773000000000000000
       Other Current Assets 
32
32
32
32
332
332
332
1,327
950
1,841
1,491
1,495
1,718
1,543
1,310
1,012
1,577
1,234
1,2341,5771,0121,3101,5431,7181,4951,4911,8419501,32733233233232323232
   > Long-term Assets 
633
633
633
633
576
576
576
2,304
2,079
3,088
3,328
3,639
2,560
2,680
2,893
3,690
3,472
10,309
10,3093,4723,6902,8932,6802,5603,6393,3283,0882,0792,304576576576633633633633
       Property Plant Equipment 
613
613
613
613
553
553
553
2,212
1,987
2,432
2,223
1,979
2,468
2,588
2,801
3,598
3,380
3,404
3,4043,3803,5982,8012,5882,4681,9792,2232,4321,9872,212553553553613613613613
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,813
6,81300000000000000000
       Long-term Assets Other 
20
20
20
20
23
23
23
92
92
656
1,105
1,660
92
92
92
92
92
92
9292929292921,6601,105656929223232320202020
> Total Liabilities 
9,166
9,166
9,166
9,166
10,309
10,309
10,309
41,237
46,744
48,194
38,520
41,314
11,925
9,107
10,044
8,420
9,592
7,510
7,5109,5928,42010,0449,10711,92541,31438,52048,19446,74441,23710,30910,30910,3099,1669,1669,1669,166
   > Total Current Liabilities 
3,623
3,623
3,623
3,623
5,621
5,621
5,621
22,483
29,455
30,564
21,448
31,626
10,543
7,878
8,755
6,554
7,805
5,803
5,8037,8056,5548,7557,87810,54331,62621,44830,56429,45522,4835,6215,6215,6213,6233,6233,6233,623
       Short-term Debt 
901
901
901
901
1,539
1,539
1,539
6,557
7,861
7,838
8,346
16,665
2,233
650
607
653
584
500
5005846536076502,23316,6658,3467,8387,8616,5571,5391,5391,539901901901901
       Short Long Term Debt 
0
0
0
0
0
0
0
6,155
7,430
7,480
8,033
16,399
1,665
65
40
0
0
0
00040651,66516,3998,0337,4807,4306,1550000000
       Accounts payable 
927
927
927
927
1,116
1,116
1,116
4,462
4,469
5,402
5,352
6,775
5,292
4,484
4,009
3,784
5,313
4,786
4,7865,3133,7844,0094,4845,2926,7755,3525,4024,4694,4621,1161,1161,116927927927927
       Other Current Liabilities 
1,795
1,795
1,795
1,795
1,842
1,842
1,842
6,964
7,165
7,364
7,690
8,016
3,018
7,228
8,148
2,117
1,908
517
5171,9082,1178,1487,2283,0188,0167,6907,3647,1656,9641,8421,8421,8421,7951,7951,7951,795
   > Long-term Liabilities 
5,543
5,543
5,543
5,543
4,689
4,689
4,689
18,754
17,289
17,630
17,072
9,688
1,382
1,229
1,289
1,866
1,787
1,707
1,7071,7871,8661,2891,2291,3829,68817,07217,63017,28918,7544,6894,6894,6895,5435,5435,5435,543
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
1,013
1,568
0
0
0
0
0
0
0000001,5681,0130000000000
> Total Stockholder Equity
-5,664
-5,664
-5,664
-5,664
-8,278
-8,278
-8,278
-33,111
-36,540
-39,063
-32,331
-35,783
2,691
22,256
24,028
19,473
15,084
37,669
37,66915,08419,47324,02822,2562,691-35,783-32,331-39,063-36,540-33,111-8,278-8,278-8,278-5,664-5,664-5,664-5,664
   Common Stock
2
2
2
2
2
2
2
9
27
9
9
9
25
26
27
27
27
35
3527272726259992792222222
   Retained Earnings -235,950-229,374-221,524-214,757-209,412-203,591-189,784-186,289-191,198-188,378-184,577-46,144-46,144-46,144-42,057-42,057-42,057-42,057
   Accumulated Other Comprehensive Income 
-461
-461
-461
-461
-599
-599
-599
2
2
2
2
2
2
2
2
14
-5
-11
-11-51422222222-599-599-599-461-461-461-461
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
206,688
232,073
0
0
0
0
0000232,073206,688000000000000
   Treasury Stock0000-433-433000000000000
   Other Stockholders Equity 
36,852
36,852
36,852
36,852
38,464
38,464
38,464
151,433
151,787
152,102
153,925
153,968
206,255
231,640
238,756
240,956
244,436
273,595
273,595244,436240,956238,756231,640206,255153,968153,925152,102151,787151,43338,46438,46438,46436,85236,85236,85236,852



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue170
Cost of Revenue-1,018
Gross Profit-848-848
 
Operating Income (+$)
Gross Profit-848
Operating Expense-23,317
Operating Income-24,165-24,165
 
Operating Expense (+$)
Research Development12,767
Selling General Administrative11,568
Selling And Marketing Expenses-1,018
Operating Expense23,31723,317
 
Net Interest Income (+$)
Interest Income244
Interest Expense-822
Other Finance Cost-3,787
Net Interest Income-4,365
 
Pretax Income (+$)
Operating Income-24,165
Net Interest Income-4,365
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-28,297-20,033
EBIT - interestExpense = -24,987
-27,447
-27,475
Interest Expense822
Earnings Before Interest and Taxes (EBIT)-24,165-27,475
Earnings Before Interest and Taxes (EBITDA)-23,147
 
After tax Income (+$)
Income Before Tax-28,297
Tax Provision-0
Net Income From Continuing Ops-25,025-28,297
Net Income-28,297
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses24,335
Total Other Income/Expenses Net-4,1324,365
 

Technical Analysis of Genelux
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genelux. The general trend of Genelux is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genelux's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genelux Corporation Common Stock.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.34 < 3.5 < 3.5.

The bearish price targets are: 2.4085 > 1.95 > 1.95.

Tweet this
Genelux Corporation Common Stock Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genelux Corporation Common Stock. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genelux Corporation Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genelux Corporation Common Stock. The current macd is 0.13270942.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genelux price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Genelux. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Genelux price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Genelux Corporation Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartGenelux Corporation Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genelux Corporation Common Stock. The current adx is 39.54.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genelux shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Genelux Corporation Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genelux Corporation Common Stock. The current sar is 2.55244098.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Genelux Corporation Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genelux Corporation Common Stock. The current rsi is 53.05. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Genelux Corporation Common Stock Daily Relative Strength Index (RSI) ChartGenelux Corporation Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genelux Corporation Common Stock. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genelux price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genelux Corporation Common Stock Daily Stochastic Oscillator ChartGenelux Corporation Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genelux Corporation Common Stock. The current cci is -4.15740428.

Genelux Corporation Common Stock Daily Commodity Channel Index (CCI) ChartGenelux Corporation Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genelux Corporation Common Stock. The current cmo is -1.55273177.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Genelux Corporation Common Stock Daily Chande Momentum Oscillator (CMO) ChartGenelux Corporation Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genelux Corporation Common Stock. The current willr is -54.97022446.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Genelux is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Genelux Corporation Common Stock Daily Williams %R ChartGenelux Corporation Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genelux Corporation Common Stock.

Genelux Corporation Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genelux Corporation Common Stock. The current atr is 0.26101282.

Genelux Corporation Common Stock Daily Average True Range (ATR) ChartGenelux Corporation Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genelux Corporation Common Stock. The current obv is -825,447.

Genelux Corporation Common Stock Daily On-Balance Volume (OBV) ChartGenelux Corporation Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genelux Corporation Common Stock. The current mfi is 51.65.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Genelux Corporation Common Stock Daily Money Flow Index (MFI) ChartGenelux Corporation Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genelux Corporation Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Genelux Corporation Common Stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genelux Corporation Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.051
Ma 20Greater thanMa 502.903
Ma 50Greater thanMa 1002.613
Ma 100Greater thanMa 2002.365
OpenGreater thanClose2.920
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Genelux with someone you think should read this too:
  • Are you bullish or bearish on Genelux? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genelux? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genelux Corporation Common Stock

I send you an email if I find something interesting about Genelux Corporation Common Stock.


Comments

How you think about this?

Leave a comment

Stay informed about Genelux Corporation Common Stock.

Receive notifications about Genelux Corporation Common Stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.